Ambar Protein Industries reports promoter Pradeep Khetani's open‑market purchase of 9,738 shares (0.17%)
On 25 June 2026, promoter Pradeep Kumar Chunilal Khetani bought 9,738 equity shares of Ambar Protein Industries, raising his stake to 12.83% of the company's share capital.
What Ambar Protein Industries announced
Ambar Protein Industries Ltd filed a disclosure with BSE on 30 June 2026, reporting that promoter Pradeep Kumar Chunilal Khetani acquired 9,738 equity shares of the company in an open‑market transaction dated 25 June 2026. The purchase represents 0.17% of the total share capital and lifts the promoter’s holding to 12.83% of the voting equity.
"The acquisition brings the promoter’s total shareholding to 12.83% of Ambar Protein Industries Ltd." – filing excerpt, 26 June 2026.
The filing satisfies the requirements of Regulation 29(2) of the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, which mandates public disclosure of any acquisition that alters a shareholder’s percentage stake.
Details of the acquisition
| Detail | Value |
|---|---|
| Acquirer | Pradeep Kumar Chunilal Khetani (promoter group) |
| Shares acquired | 9,738 equity shares |
| Percentage of total share capital acquired | 0.17% |
| Mode of acquisition | Open market purchase |
| Date of acquisition | 25 June 2026 |
| Pre‑acquisition holding | 727,913 shares (12.66%) |
| Post‑acquisition holding | 737,651 shares (12.83%) |
| Total equity share capital (pre & post) | 57,50,000 shares (Rs 5.75 crore) |
| Filing date with BSE | 30 June 2026 |
| Regulation invoked | SEBI Regulation 29(2) |
The promoter’s pre‑acquisition holding of 727,913 shares accounted for 12.66% of the company’s voting equity. After adding the newly purchased 9,738 shares, the holding increased to 737,651 shares, translating to 12.83% of the total voting capital. The share capital of the company remains unchanged at 57.5 million shares, each with a face value of Rs 10.
Mode and timing of the transaction
The acquisition was carried out through open‑market transactions, meaning the shares were bought on the stock exchange rather than via a private placement, preferential allotment, or any other off‑market mechanism. The filing specifies the exact date of purchase as 25 June 2026, and the disclosure was submitted the following day, 26 June 2026, with the formal filing to BSE recorded on 30 June 2026.
No new shares were issued, and there was no change to the company’s authorized or paid‑up capital. Consequently, the transaction does not dilute existing shareholders, nor does it trigger any rights issue or capital restructuring.
Key facts at a glance
| Detail | Value |
|---|---|
| Company | Ambar Protein Industries Ltd |
| BSE Code | 519471 |
| Acquirer | Pradeep Kumar Chunilal Khetani |
| Shares bought | 9,738 |
| % of total share capital | 0.17% |
| Pre‑acquisition stake | 12.66% |
| Post‑acquisition stake | 12.83% |
| Mode | Open market |
| Acquisition date | 25 June 2026 |
| Filing date | 30 June 2026 |
| Regulation | SEBI (SAST) Reg. 29(2) |
Why this matters for investors
The filing is primarily a compliance requirement under SEBI’s takeover regulations. It informs the market that a promoter has increased his equity position, which can be interpreted as a sign of confidence in the company’s prospects. However, the increase is modest—0.17% of the total share capital—and does not materially alter the promoter’s control dynamics.
Because the transaction was executed on the open market, there is no dilution of existing shareholders’ equity. The company’s capital structure, including the total number of shares and share price, remains unchanged. Investors should note that the disclosure does not indicate any intent to acquire additional shares beyond the reported amount, nor does it hint at any forthcoming corporate actions such as a rights issue, merger, or asset sale.
Regulatory compliance is essential for maintaining market transparency. By filing under Regulation 29(2), Ambar Protein Industries ensures that all market participants have timely access to material shareholding changes, thereby upholding the integrity of the securities market.
Conclusion
Ambar Protein Industries Ltd disclosed that promoter Pradeep Kumar Chunilal Khetani purchased 9,738 shares on 25 June 2026, raising his stake from 12.66% to 12.83%. The open‑market acquisition did not affect the company’s share capital, and the filing satisfies SEBI’s disclosure obligations. No further share‑related actions have been announced, and the company’s capital structure remains unchanged.
FAQs
-
Who acquired shares of Ambar Protein Industries? The shares were acquired by Pradeep Kumar Chunilal Khetani, who is identified in the filing as belonging to the promoter group.
-
How many shares were bought and what percentage of the company does that represent? A total of 9,738 equity shares were purchased, representing 0.17% of the company’s total share capital.
-
What was the promoter’s holding before and after the purchase? Before the acquisition the promoter held 727,913 shares (12.66%). After the purchase the holding increased to 737,651 shares (12.83%).
-
Did the transaction change the company’s total share capital? No. The total equity share capital remained at 57,50,000 shares (Rs 5.75 crore) before and after the transaction.
-
When was the acquisition made and when was it disclosed? The open‑market purchase occurred on 25 June 2026. The disclosure was submitted to BSE on 26 June 2026, with the formal filing recorded on 30 June 2026.
-
Does the filing indicate any future share‑related plans? The filing does not disclose any future acquisitions, disposals, or other corporate actions beyond the reported purchase.
Related stocks
Source filing: view original